Results 31 to 40 of about 322,248 (364)

Human papillomavirus and HPV vaccines: a review [PDF]

open access: yes, 2007
Cervical cancer, the most common cancer affecting women in developing countries, is caused by persistent infection with "high-risk" genotypes of human papillomaviruses (HPV). The most common oncogenic HPV genotypes are 16 and 18, causing approximately 70%
Castellsague, X.   +10 more
core   +3 more sources

E5 protein of human papillomavirus 16 downregulates HLA class I and interacts with the heavy chain via its first hydrophobic domai [PDF]

open access: yes, 2006
Human papillomavirus type 16 E5 protein (HPV-16 E5) is expressed early in papillomavirus infection and is localised primarily in the cell Golgi apparatus (GA) and endoplasmic reticulum. E5 prevents transport of the major histocompatibility class I (MHC I;
Adam   +30 more
core   +1 more source

Mus musculus papillomavirus 1 E8^E2 represses expression of late protein E4 in basal-like keratinocytes via NCoR/SMRT-HDAC3 co-repressor complexes to enable wart formation in vivo

open access: yesmBio, 2023
High-risk human papillomaviruses (PV) account for approximately 600,000 new cancers per year. The early protein E8^E2 is a conserved repressor of PV replication, whereas E4 is a late protein that arrests cells in G2 and collapses keratin filaments to ...
Franziska Kuehner   +6 more
doaj   +1 more source

Equine sarcoids: Bovine Papillomavirus type 1 transformed fibroblasts are sensitive to cisplatin and UVB induced apoptosis and show aberrant expression of p53 [PDF]

open access: yes, 2012
Bovine papillomavirus type 1 infects not only cattle but also equids and is a causative factor in the pathogenesis of commonly occurring equine sarcoid tumours.
Campo, M.   +4 more
core   +3 more sources

Human papillomavirus vaccines [PDF]

open access: yesCanadian Medical Association Journal, 2017
Human papillomavirus is the most common sexually transmitted infection. Persistent infection with a high-risk HPV type causes virtually all cases of cervical cancer and has been associated with 90% of anal, 70% of vaginal, 40% of vulvar and 65% of penile cancers,[1][1] as well as up to 70 ...
Shainoor J, Ismail, Shelley L, Deeks
openaire   +2 more sources

Human papillomavirus vaccination coverage in Luxembourg : implications of lowering and restricting target age groups [PDF]

open access: yes, 2018
Background: In Luxembourg, a national Human Papillomavirus (HPV) vaccination programme was introduced in 2008, targeting 12-17 year old girls offering a choice of bivalent or quadrivalent vaccine free of charge.
Arbyn, Marc   +3 more
core   +2 more sources

Factors associated with pregnancy and STI among Aboriginal students in British Columbia. [PDF]

open access: yes, 2009
BACKGROUND: Aboriginal adolescents are more likely to become pregnant and contract an STI than other Canadian adolescents. This study provides some of the first data on factors associated with these outcomes among Aboriginal adolescents.
Devries, Karen M   +3 more
core   +1 more source

Tumeur de Buschke-Lowenstein à localisation pénienne

open access: yesThe Pan African Medical Journal, 2020
La tumeur de Buschke-Lowenstein (TBL) ou condylome acuminé géant (CAG) est une affection rare, d´origine virale appartenant au groupe des carcinomes verruqueux.
Ahmed Ibrahimi, Idriss Ziani
doaj   +1 more source

Bovine Papillomavirus 1 Gets Out of the Flock: Detection in an Ovine Wart in Sicily

open access: yesPathogens, 2020
A proliferative cauliflower lesion was excised from the udder of a sheep. Histological investigation confirmed the macroscopic classification of the lesion as a papilloma, without any fibroblastic proliferation.
Federica Savini   +10 more
doaj   +1 more source

Human Papillomavirus Vaccination for Adults: Updated Recommendations of the Advisory Committee on Immunization Practices

open access: yesMMWR. Morbidity and mortality weekly report, 2019
Vaccination against human papillomavirus (HPV) is recommended to prevent new HPV infections and HPV-associated diseases, including some cancers. The Advisory Committee on Immunization Practices (ACIP)* routinely recommends HPV vaccination at age 11 or 12
E. Meites   +5 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy